Lifevantage Corporation Common Stock (Delaware) (LFVN)

Price$9.97

Value ScoreC

Growth ScoreD

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)37.20%

Price vs S&P 500 (4W)86.71%

VGM Score53.50

Market Capitalization$125.78M

P/E Ratio (Annual)12.83x

Indicated Dividend Yield (Annual)2.15%

All Metrics

P/CF (Annual)10.59x

Book Value / Share (Quarterly)$2.64

P/TBV (Annual)4.73x

Indicated Dividend (Annual)$0.20

Revenue Growth (3Y)3.45%

Cash Flow / Share (Quarterly)$0.30

Payout Ratio (TTM)39.66%

Price vs S&P 500 (YTD)53.69%

Gross Margin (TTM)78.14%

Net Profit Margin (TTM)2.94%

EPS (TTM)$0.45

10-Day Avg Trading Volume1.09M

EPS Excl Extra (TTM)$0.45

Revenue Growth (5Y)-0.38%

EPS (Annual)$0.76

Dividend / Share (Annual)$0.17

ROI (Annual)28.30%

Gross Margin (Annual)80.37%

Net Profit Margin (5Y Avg)2.86%

Cash / Share (Quarterly)$0.99

P/E Basic Excl Extra (TTM)21.87x

Revenue Growth QoQ (YoY)-25.20%

EPS Growth (5Y)-0.84%

P/E Normalized (Annual)12.83x

ROA (Last FY)13.63%

Revenue Growth TTM (YoY)-12.15%

EBITD / Share (TTM)$0.73

ROE (5Y Avg)18.34%

Operating Margin (TTM)3.37%

Cash Flow / Share (Annual)$0.85

P/B Ratio3.77x

P/B Ratio (Quarterly)1.66x

Net Income / Employee (Annual)$42,300

EV / Revenue (TTM)0.58x

Net Interest Coverage (TTM)21.00x

ROA (TTM)8.96%

EPS Growth QoQ (YoY)-58.76%

EV / EBITDA (TTM)12.04x

EPS Incl Extra (Annual)$0.76

Current Ratio (Annual)1.87x

Quick Ratio (Quarterly)0.85x

3-Month Avg Trading Volume0.29M

52-Week Price Return-19.47%

EV / Free Cash Flow (Annual)10.78x

P/E Incl Extra (TTM)21.87x

Revenue / Employee (TTM)$841,900

Tangible BV / Share (Quarterly)$2.39

P/S Ratio (Annual)0.55x

Asset Turnover (Annual)3.18x

52-Week High$15.00

Operating Margin (5Y Avg)4.02%

EPS Excl Extra (Annual)$0.76

CapEx CAGR (5Y)-12.55%

Tangible BV CAGR (5Y)1.20%

26-Week Price Return45.12%

Quick Ratio (Annual)0.89x

13-Week Price Return112.13%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.96x

Enterprise Value$113.30M

Revenue / Share Growth (5Y)1.98%

Asset Turnover (TTM)3.04x

Book Value / Share Growth (5Y)3.70%

Revenue / Employee (Annual)$985,000

Inventory Turnover (Annual)2.51x

Pretax Margin (Annual)5.36%

Cash / Share (Annual)$1.63

3-Month Return Std Dev98.55%

Gross Margin (5Y Avg)80.70%

Net Income / Employee (TTM)$24,800

EBITDA CAGR (5Y)-3.43%

EBITDA Interim CAGR (5Y)-4.11%

ROE (Last FY)28.30%

Net Interest Coverage (Annual)115.62x

EPS Basic Excl Extra (Annual)$0.76

P/FCF (TTM)19.29x

Receivables Turnover (TTM)69.02x

EV / Free Cash Flow (TTM)30.01x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.45

Receivables Turnover (Annual)73.21x

ROI (TTM)17.15%

P/S Ratio (TTM)0.64x

Pretax Margin (5Y Avg)3.90%

Revenue / Share (Annual)$17.60

Tangible BV / Share (Annual)$2.77

Forward P/E16.86x

Free OCF CAGR (5Y)-7.66%

Price vs S&P 500 (52W)-43.83%

P/E Ratio (TTM)21.87x

EPS Growth TTM (YoY)-36.01%

Year-to-Date Return61.85%

5-Day Price Return5.73%

EPS Normalized (Annual)$0.76

ROA (5Y Avg)8.61%

Net Profit Margin (Annual)4.29%

Month-to-Date Return26.68%

Cash Flow / Share (TTM)$0.49

EBITD / Share (Annual)$1.18

EPS Growth (3Y)47.22%

Operating Margin (Annual)5.34%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)19.33x

ROI (5Y Avg)18.34%

P/E Excl Extra (TTM)21.87x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.45

P/TBV (Quarterly)1.83x

Payout Ratio (Annual)21.08%

P/B Ratio (Annual)4.69x

Dividend / Share (TTM)$0.18

Inventory Turnover (TTM)2.10x

Pretax Margin (TTM)3.46%

Book Value / Share (Annual)$2.79

Price vs S&P 500 (13W)103.87%

Net Margin Growth (5Y)-2.78%

Dividend Yield (TTM)1.81%

Beta0.67x

P/FCF (Annual)11.97x

Revenue / Share (TTM)$15.43

ROE (TTM)17.15%

52-Week Low$3.90

vGradeC

gGradeD

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q3 260.12est. 0.16

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.13

4.00

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
LFVNLifevantage Corporation Common Stock (Delaware)	C	D	B	$9.97
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

LifeVantage develops and distributes nutraceutical supplements and skincare products, including Protandim, LifeVantage TrueScience, Axio energy drinks, and PhysIQ. The company operates in ten countries across North America, Asia-Pacific, and Europe. Its products are positioned as scientifically-validated wellness solutions for health-conscious consumers.